← Open Payments lookup

MICHELE TANZ: Open Payments

NPI 1013222983 · SHENANDOAH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,942 in 121 payments from 18 companies in 2025. Trend: 2023 $3,769 · 2024 $2,665 · 2025 $2,942

Food & beverage: $2,931Education: $10
CompanyPaymentsAmount
ABBVIE INC.32$686
Aimmune Therapeutics, Inc.16$363
Janssen Biotech, Inc.15$346
Madrigal Pharmaceuticals7$230
GENZYME CORPORATION5$224
Salix Pharmaceuticals, a division of Bausch Health US, LLC10$194
Ipsen Biopharmaceuticals, Inc5$180
PFIZER INC.6$178
Takeda Pharmaceuticals U.S.A., Inc.11$136
VERTEX PHARMACEUTICALS INCORPORATED1$125

Products named: RINVOQ, TREMFYA, DUPIXENT, ZENPEP, REZDIFFRA, XIFAXAN, IQIRVO, VELSIPITY.

Industry payments across TX — which companies pay providers there.